Metastatic eccrine porocarcinoma successfully treated with carboplatin and epirubicin chemotherapy
Keitaro Fukuda
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
Search for more papers by this authorCorresponding Author
Takeru Funakoshi
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
Correspondence: Takeru Funakoshi, MD., PhD., Department of Dermatology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo 160-8582, Japan. Email: [email protected]Search for more papers by this authorMasahiro Fukuyama
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
Search for more papers by this authorRisa Kakuta
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
Search for more papers by this authorMisato Sato
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
Search for more papers by this authorYoshio Nakamura
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
Search for more papers by this authorKeiji Tanese
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
Search for more papers by this authorYohei Masugi
Department of Pathology, Keio University School of Medicine, Tokyo, Japan
Search for more papers by this authorMasayuki Amagai
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
Search for more papers by this authorKeitaro Fukuda
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
Search for more papers by this authorCorresponding Author
Takeru Funakoshi
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
Correspondence: Takeru Funakoshi, MD., PhD., Department of Dermatology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo 160-8582, Japan. Email: [email protected]Search for more papers by this authorMasahiro Fukuyama
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
Search for more papers by this authorRisa Kakuta
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
Search for more papers by this authorMisato Sato
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
Search for more papers by this authorYoshio Nakamura
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
Search for more papers by this authorKeiji Tanese
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
Search for more papers by this authorYohei Masugi
Department of Pathology, Keio University School of Medicine, Tokyo, Japan
Search for more papers by this authorMasayuki Amagai
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
Search for more papers by this author
References
- 1Robson A, Greene J, Ansari N et al. Eccrine porocarcinoma (malignant eccrine poroma): a clinicopathologic study of 69 cases. Am J Surg Pathol 2001; 25: 710–720.
- 2De Iuliis F, Amoroso L, Taglieri L et al. Chemotherapy of rare skin adnexal tumors: a review of literature. Anticancer Res 2014; 34: 5263–5268.
- 3Plunkett TA, Hanby AM, Miles DW, Rubens RD. Metastatic eccrine porocarcinoma: response to docetaxel (Taxotere) chemotherapy. Ann Oncol 2001; 12: 411–414.
- 4O'Neill VJ, Kaye SB, Reed NS, Paul J, Davis JA, Vasey PA. A dose-finding study of carboplatin-epirubicin-docetaxel in advanced epithelial ovarian cancer. Br J Cancer 2002; 86: 1385–1390.
10.1038/sj.bjc.6600259 Google Scholar
- 5Rossi A, Di Maio M, Chiodini P et al. Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data. J Clin Oncol 2012; 30: 1692–1698.
Citing Literature
